Merck appoints Regional VP for MEAR

Ramsey Morad to lead the Healthcare business for Merck in Middle East, Africa, Turkey and Russia & CIS

  
Merck appoints Regional VP for MEAR

Dubai, United Arab Emirates – Merck, a leading science and technology company, recently appointed Ramsey Morad as Regional Vice President for the Healthcare business in Middle East, Africa, Turkey and Russia & CIS (MEAR). Morad is now responsible for leading all business operations of Merck's Healthcare business in this region.

Morad is a well-regarded and experienced pharmaceutical executive with more than 25 years of industry experience across Europe, the Middle East and Africa.

“I am very excited to join Merck, a leader in science and technology, and head such a dedicated and driven organization. With its innovative, research-driven, specialty healthcare solutions, Merck is well-positioned to respond to the patients’ needs across the region and help them live a better life. I look forward to contributing to that by expanding our portfolio as well as extending its reach,“ said Morad.

Merck’s Healthcare business in MEAR is represented in the therapeutic areas of General Medicine and Endocrinology (including Cardiometabolic Care), Fertility, Neurodegenerative Diseases and Oncology.

Joining from Allergan, Morad was the VP and Region Head of India, Middle East and Africa, leading the organization across 24 markets. Prior to Allergan, Morad was with Shire, in charge of the Eurasia, Middle East and Africa Region, where he led the integration efforts with Baxalta, established and expanded the company’s geographical footprint. Prior to Shire, Morad spent 17 years with MSD working in different roles of increasing responsibility across 6 countries including in regional leadership, general management and regional marketing.

Morad is a pharmacist with an MBA from Henley Business School. He was born and raised in the United States and over the years had the opportunity to live and work in several countries in Europe and the Middle East.

About Merck

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.

For more information, please contact:
Chandni Chugh
PR Consultant
chandni@sherpacomms.com  

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases